If you or a loved one rely on Hormone Replacement Therapy (HRT), you might have noticed some supply issues lately. The Department of Health has confirmed that two major brands—Estradot and FemSeven Conti—are dealing with manufacturing and distribution delays.
The current sitch
It’s super frustrating when you finally find a routine that works for your body and then it goes out of stock. Pharmacist Paul Irvine and Dr. Ursula Mason, chair of the Royal College of General Practitioners Northern Ireland, are flagging that trying to swap brands on your own can be risky. You might end up dealing with side effects or just not feeling the same relief. Real talk: don't share your meds with friends, either, because what hits for you might not be the right vibe for someone else.
How to handle the shortage
If you can’t get your usual patches, reach out to your GP or pharmacist. They can point you toward alternatives that contain the exact same active ingredients at the same dose. In some cases, pharmacists can even swap your prescription for an alternative without you needing a new note from the doctor, thanks to "Serious Shortage Protocols" currently active until January 8, 2027.
Roisin Hillman from the charity Menopause Together says some people have reported issues like skin irritation or patches not sticking when switching brands. If the new formula isn't working for you, don't just deal with it—head back to your doctor to find a better fit. She also recommends asking your GP about getting longer-term prescriptions to stay ahead of future gaps.
Why it matters
HRT is a game-changer for many women managing menopause symptoms, and losing access to a consistent treatment can cause major anxiety. Keeping your doctor in the loop ensures you're staying safe while navigating these supply chain Ls.
